Your browser doesn't support javascript.
loading
Recombinant Human Thymosin ß4 (rhTß4) Modulates the Anti-Inflammatory Responses to Alleviate Benzalkonium Chloride (BAC)-Induced Dry Eye Disease.
Zhai, Yanfang; Zheng, Xiaoxiang; Mao, Yunyun; Li, Kai; Liu, Yanhong; Gao, Yuemei; Zhao, Mengsu; Yang, Rui; Yu, Rui; Chen, Wei.
Afiliação
  • Zhai Y; Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China.
  • Zheng X; Eye Institute of Xiamen University & Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, School of Medicine, Xiamen University, Xiamen 361104, China.
  • Mao Y; Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China.
  • Li K; Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China.
  • Liu Y; Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China.
  • Gao Y; Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China.
  • Zhao M; Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China.
  • Yang R; Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China.
  • Yu R; Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China.
  • Chen W; Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China.
Int J Mol Sci ; 23(10)2022 May 13.
Article em En | MEDLINE | ID: mdl-35628276
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Benzalcônio / Síndromes do Olho Seco Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Benzalcônio / Síndromes do Olho Seco Idioma: En Ano de publicação: 2022 Tipo de documento: Article